Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
    Sinovac to distribute LG Life Sciences vaccines in China 3/16/2006
     BEIJING (AFX) - China's Sinovac Biotech Ltd (Sinovac) and Korean pharmaceutical firm LG Life Sciences, Ltd (LGLS) have signed a vaccine distribution agreement, the companies said in a joint statement.

    Under the terms of the agreement, Sinovac will act as the sole distributor of LGLS's hepatitis B vaccine in China.

    'Partnering with Sinovac is an exceptional opportunity for LGLS to execute our business strategy; which is to secure global marketing capabilities,' said In-Chull Kim, LGLS' chief executive.

    Euvax B, LGLS's hepatitis B vaccine, is being exported to over 60 countries, including UN-sponsored programs.

    Sinovac has developed vaccines for SARS and pandemic flu (H5N1).

    Relate News
  • Site map | Contact Us | Links
  • © Wicon International Group